R. Hilgenfeld

5.0k total citations · 3 hit papers
29 papers, 3.8k citations indexed

About

R. Hilgenfeld is a scholar working on Molecular Biology, Infectious Diseases and Animal Science and Zoology. According to data from OpenAlex, R. Hilgenfeld has authored 29 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 11 papers in Infectious Diseases and 6 papers in Animal Science and Zoology. Recurrent topics in R. Hilgenfeld's work include Viral gastroenteritis research and epidemiology (8 papers), SARS-CoV-2 and COVID-19 Research (8 papers) and Animal Virus Infections Studies (6 papers). R. Hilgenfeld is often cited by papers focused on Viral gastroenteritis research and epidemiology (8 papers), SARS-CoV-2 and COVID-19 Research (8 papers) and Animal Virus Infections Studies (6 papers). R. Hilgenfeld collaborates with scholars based in Germany, United States and China. R. Hilgenfeld's co-authors include J.R. Mesters, K. Anand, John Ziebuhr, Parvesh Wadhwani, Zihe Rao, Haitao Yang, Mark Bartlam, Maojun Yang, Hai Pang and Lei Sun and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

R. Hilgenfeld

28 papers receiving 3.7k citations

Hit Papers

Coronavirus Main Proteinase (3CL pro ) Structure: Basis f... 2003 2026 2010 2018 2003 2003 2005 400 800 1.2k

Peers

R. Hilgenfeld
K. Anand Germany
J.R. Mesters Germany
Kiira Ratia United States
William C. Groutas United States
Ute Curth Germany
Hai Pang China
Yanmei Hu United States
Jun Lan China
Hideki Aihara United States
K. Anand Germany
R. Hilgenfeld
Citations per year, relative to R. Hilgenfeld R. Hilgenfeld (= 1×) peers K. Anand

Countries citing papers authored by R. Hilgenfeld

Since Specialization
Citations

This map shows the geographic impact of R. Hilgenfeld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Hilgenfeld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Hilgenfeld more than expected).

Fields of papers citing papers by R. Hilgenfeld

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Hilgenfeld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Hilgenfeld. The network helps show where R. Hilgenfeld may publish in the future.

Co-authorship network of co-authors of R. Hilgenfeld

This figure shows the co-authorship network connecting the top 25 collaborators of R. Hilgenfeld. A scholar is included among the top collaborators of R. Hilgenfeld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Hilgenfeld. R. Hilgenfeld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mesters, J.R., et al.. (2024). Practical courses on advanced methods in macromolecular crystallization: 20 years of history and future perspectives. Journal of Applied Crystallography. 57(5). 1609–1617.
2.
Schmidt, Helgo, J.R. Mesters, Jing Wu, et al.. (2011). Evidence for a Two-Metal-Ion Mechanism in the Cytidyltransferase KdsB, an Enzyme Involved in Lipopolysaccharide Biosynthesis. PLoS ONE. 6(8). e23231–e23231. 12 indexed citations
3.
Tan, Jinzhi, Clemens Vonrhein, Oliver S. Smart, et al.. (2009). The SARS-Unique Domain (SUD) of SARS Coronavirus Contains Two Macrodomains That Bind G-Quadruplexes. PLoS Pathogens. 5(5). e1000428–e1000428. 134 indexed citations
4.
Mamat, Uwe, Helgo Schmidt, Eva Muñoz, et al.. (2009). WaaA of the Hyperthermophilic Bacterium Aquifex aeolicus Is a Monofunctional 3-Deoxy-d-manno-oct-2-ulosonic Acid Transferase Involved in Lipopolysaccharide Biosynthesis. Journal of Biological Chemistry. 284(33). 22248–22262. 28 indexed citations
5.
Verschueren, Koen H. G., Ksenia Pumpor, Stefan Anemüller, et al.. (2008). A Structural View of the Inactivation of the SARS Coronavirus Main Proteinase by Benzotriazole Esters. Chemistry & Biology. 15(6). 597–606. 65 indexed citations
6.
Moll, Ralf, et al.. (2008). Variable Oligomerization Modes in Coronavirus Non-structural Protein 9. Journal of Molecular Biology. 383(5). 1081–1096. 43 indexed citations
7.
Mesters, J.R., et al.. (2007). Human glutamate carboxypeptidase II inhibition: structures of GCPII in complex with two potent inhibitors, quisqualate and 2-PMPA. Acta Crystallographica Section D Biological Crystallography. 63(4). 508–513. 34 indexed citations
8.
Mesters, J.R., et al.. (2006). Non Structural Proteins 8 and 9 of Human Coronavirus 229E. Advances in experimental medicine and biology. 581. 49–54. 2 indexed citations
9.
Mesters, J.R., Cyril Bařinka, Weixing Li, et al.. (2006). Structure of glutamate carboxypeptidase II, a drug target in neuronal damage and prostate cancer. The EMBO Journal. 25(6). 1375–1384. 214 indexed citations
10.
Groneberg, David A., R. Hilgenfeld, & P. Zabel. (2005). Molecular mechanisms of severe acute respiratory syndrome (SARS). Respiratory Research. 6(1). 8–8. 71 indexed citations
11.
Yang, Haitao, Maojun Yang, Yi Ding, et al.. (2003). The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor. Proceedings of the National Academy of Sciences. 100(23). 13190–13195. 773 indexed citations breakdown →
12.
Weber, Jan, J.R. Mesters, Martin Lepšı́k, et al.. (2002). Unusual Binding Mode of an HIV-1 Protease Inhibitor Explains its Potency against Multi-drug-resistant Virus Strains. Journal of Molecular Biology. 324(4). 739–754. 43 indexed citations
13.
Anand, K., Debnath Pal, & R. Hilgenfeld. (2002). An overview on 2-methyl-2,4-pentanediol in crystallization and in crystals of biological macromolecules. Acta Crystallographica Section D Biological Crystallography. 58(10). 1722–1728. 49 indexed citations
14.
Hogg, Tim, J.R. Mesters, & R. Hilgenfeld. (2002). Inhibitory Mechanisms of Antibiotics Targeting Elongation Factor Tu. Current Protein and Peptide Science. 3(1). 121–131. 28 indexed citations
15.
Vogeley, Lutz, Gottfried J. Palm, J.R. Mesters, & R. Hilgenfeld. (2001). Conformational Change of Elongation Factor Tu (EF-Tu) Induced by Antibiotic Binding. Journal of Biological Chemistry. 276(20). 17149–17155. 100 indexed citations
16.
Zuurmond, Anne‐Marie, et al.. (2000). GE2270A-resistant Mutations in Elongation Factor Tu Allow Productive Aminoacyl-tRNA Binding to EF-Tu·GTP·GE2270A Complexes. Journal of Molecular Biology. 304(5). 995–1005. 17 indexed citations
17.
Krásný, Libor, J.R. Mesters, Barend Kraal, et al.. (1998). Structure and expression of elongation factor tu from Bacillus stearothermophilus 1 1Edited by D. Draper. Journal of Molecular Biology. 283(2). 371–381. 17 indexed citations
18.
Zeef, Leo, J.R. Mesters, Kathy Boon, et al.. (1995). Antibiotic resistance mechanisms of mutant EF-Tu species in Escherichia coli. Biochemistry and Cell Biology. 73(11-12). 1167–1177. 22 indexed citations
19.
Bilgin, N., Carsten Lindschau, J.R. Mesters, et al.. (1995). Phosphorylation of Elongation Factor Tu Prevents Ternary Complex Formation. Journal of Biological Chemistry. 270(24). 14541–14547. 66 indexed citations
20.
Hilgenfeld, R., et al.. (1990). Crystallization of blood coagulation factor XIII by an automated procedure. FEBS Letters. 265(1-2). 110–112. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026